BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

European Medicines Agency 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a


SEARCH JOBS




Industry
Services






 Company News
European Medicines Agency Accepts Application Seeking New Indication For Pfizer Inc. (PFE)'s Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults 8/7/2014 11:07:00 AM
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval Of IMBRUVICA® (Ibrutinib) For Treatment Of Two Blood Cancers 7/25/2014 8:02:37 AM
Alexion Pharmaceuticals Inc. (ALXN) Release: European Medicines Agency Accepts Marketing Authorization Application For Asfotase Alfa As A Treatment For Patients With Hypophosphatasia 7/24/2014 11:41:16 AM
Sigma-Tau Rare Disease Submits Application To The European Medicines Agency For Use Of PegylatedL-Asparaginase (Oncaspar®) In The Treatment Of Acute Lymphoblastic Leukaemia 7/10/2014 10:26:15 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces European Medicines Agency Acceptance Of Pediatric Investigation Plan For Qinprezo™ (Vosaroxin) For AML 7/9/2014 10:45:28 AM
The Medicines Company (MDCO) Receives Market Authorization Renewal For Angiox® (Bivalirudin) From The European Medicines Agency And The European Commission 7/7/2014 10:13:38 AM
TiGenix Release: European Medicines Agency Renews Marketing Authorization For Chondrocelect 7/1/2014 9:09:56 AM
Hyperion Therapeutics Announces European Medicines Agency Acceptance For Review Of Marketing Authorization Application For RAVICTI® 6/26/2014 7:38:51 AM
European Medicines Agency Release: Outcome Report On First European Collaboration Between Regulators And HTA Organisations 6/25/2014 9:03:25 AM
Agreement On Phase 3 Trial Protocol Of OSE Pharma's OSE-2101 From The FDA And European Medicines Agency 6/24/2014 6:22:00 AM
12345678910...